B2
This small molecule, known as B2 or Linazolamide intermediate B impurity 2, has been shown to induce protein aggregation in cellular models of Huntington's and Parkinson's disease. It serves as a research tool for studying neurodegenerative disease mechanisms in vitro, particularly related to pathological inclusion formation.
Product Specifications
CAS Number
115687-05-3
Product Name Alternative
Sirtuin, 5-[4- (4-Chlorobenzoyl) -1-piperazinyl]-8-nitroquinoline, B2, B-2, B 2, CPNQ, Huntington's diseases, HIF/HIFProlylHydroxylase, HIF/HIF ProlylHydroxylase, HIF Prolyl-Hydroxylase, HIF ProlylHydroxylase, HIF, Inhibitor, HIFProlylHydroxylase, Linazolamide intermediate B impurity 2, inhibit, Parkinson's diseases
Field of Research
Epigenetics & Chromatin, Metabolism Research, Molecular Biology
Purity
99.14% (May vary between batches)
Solubility
H2O:2 mg/mL (5.04 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:50 mg/mL (126 mM)
Smiles
[O-][N+] (=O) c1ccc (N2CCN (CC2) C (=O) c2ccc (Cl) cc2) c2cccnc12
Molecular Formula
C20H17ClN4O3
Molecular Weight
396.83
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
43216126 3x 1.0µg DNA
SCYL1 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details